HCA Healthcare amends bylaws to update director nomination and proxy solicitation requirements

HCA Healthcare, Inc.

Board adopted Third Amended and Restated Bylaws effective December 19, 2022.
Amendment revises Article II, Section 11 to require compliance with SEC Rule 14a-19 for director nominations and proxy solicitations.
Technical, ministerial, and conforming changes made to align with recent Delaware General Corporation Law amendments.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

HCA Healthcare, Inc.: Amended and restated bylaws to revise director nomination and proxy solicitation requirements, including compliance with Rule 14a-19, and incorporate technical conforming changes (effective 2022-12-19).

Change: bylaw amendment
Effective: 2022-12-19

Exact text from the filing

On December 19, 2022, the Board of Directors (the “Board”) of HCA Healthcare, Inc. (the “Company”), based on the recommendation of the Nominating and Corporate Governance Committee of the Board, adopted an amendment and restatement of the Company’s Second Amended and Restated Bylaws (as so amended, the “Third Amended Bylaws”), which became effective immediately upon adoption by the Board.

View on SEC.gov

13 governance changes filed in the last 30 days. Browse all governance changes →

HCA Healthcare, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-308372

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.